177 related articles for article (PubMed ID: 17261243)
41. Primary human immunodeficiency virus type 1 infection: clinical, virological and immunological characteristics of 75 patients (1997-2003).
Sued O; Miró JM; Alquezar A; Claramonte X; García F; Plana M; Arnedo M; de Lazzari E; Gil C; Manzardo C; Blanco JL; Martínez E; Mallolas J; Joseph J; Pumarola T; Gallart T; Gatell JM
Enferm Infecc Microbiol Clin; 2006 Apr; 24(4):238-44. PubMed ID: 16725083
[TBL] [Abstract][Full Text] [Related]
42. Tuberculosis-related mortality in people living with HIV in Europe and Latin America: an international cohort study.
Podlekareva DN; Efsen AM; Schultze A; Post FA; Skrahina AM; Panteleev A; Furrer H; Miller RF; Losso MH; Toibaro J; Miro JM; Vassilenko A; Girardi E; Bruyand M; Obel N; Lundgren JD; Mocroft A; Kirk O;
Lancet HIV; 2016 Mar; 3(3):e120-31. PubMed ID: 26939735
[TBL] [Abstract][Full Text] [Related]
43. Prognostic value of plasma HIV RNA in the natural history of Pneumocystis carinii pneumonia, cytomegalovirus and Mycobacterium avium complex. Multicenter AIDS Cohort Study.
Lyles RH; Chu C; Mellors JW; Margolick JB; Detels R; Giorgi JV; Al-Shboul Q; Phair JP
AIDS; 1999 Feb; 13(3):341-9. PubMed ID: 10199224
[TBL] [Abstract][Full Text] [Related]
44. The AIDS epidemic among Scandinavian women: 1980-1990.
Smith E; Hasseltvedt V; Böttiger M
AIDS; 1994 May; 8(5):689-92. PubMed ID: 8060549
[TBL] [Abstract][Full Text] [Related]
45. Risk factors for tuberculosis in HIV-infected persons. A prospective cohort study. The Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA).
Antonucci G; Girardi E; Raviglione MC; Ippolito G
JAMA; 1995 Jul; 274(2):143-8. PubMed ID: 7596002
[TBL] [Abstract][Full Text] [Related]
46. [Risk factors for the heterosexual transmission of HIV from man to woman: a Spanish multicenter study].
Zunzunegui V; Casabona J; Laguna J; Tor J; Ortiz C; Alameda J; González Lahoz J
Med Clin (Barc); 1992 May; 98(19):721-5. PubMed ID: 1608276
[TBL] [Abstract][Full Text] [Related]
47. [HIV and other sexually transmitted infections among migrant population in Spain: a scoping review].
Hernando Rovirola C; Ortiz-Barreda G; Galán Montemayor JC; Sabidó Espin M; Casabona Barbarà J
Rev Esp Salud Publica; 2014; 88(6):763-81. PubMed ID: 25418567
[TBL] [Abstract][Full Text] [Related]
48. [The pattern of AIDS-indicative diseases in adults and adolescents in Spain, 1988-1993].
Castilla J; Gutiérrez A; Ramos B; Camarero M; Burgoa M; Noguer I
Med Clin (Barc); 1996 Feb; 106(7):246-50. PubMed ID: 8667673
[TBL] [Abstract][Full Text] [Related]
49. AIDS incidence and survival in a hospital-based cohort of asymptomatic HIV seropositive patients in São Paulo, Brazil.
Fonseca LA; Reingold AL; Casseb JR; Brigido LF; Duarte AJ
Int J Epidemiol; 1999 Dec; 28(6):1156-60. PubMed ID: 10661662
[TBL] [Abstract][Full Text] [Related]
50. Burden of pneumocystis pneumonia in HIV-infected adults in sub-Saharan Africa: a systematic review and meta-analysis.
Wasserman S; Engel ME; Griesel R; Mendelson M
BMC Infect Dis; 2016 Sep; 16(1):482. PubMed ID: 27612639
[TBL] [Abstract][Full Text] [Related]
51. [Pneumocystis Pneumonia in 107 HIV Infected Patients Admitted to the Department of Infectious Diseases at Santa Maria Hospital, Lisbon (2002 - 2013)].
Grilo V; Pereira A
Acta Med Port; 2016 Oct; 29(10):639-650. PubMed ID: 28103460
[TBL] [Abstract][Full Text] [Related]
52. HIV infection among people of foreign origin voluntarily tested in Spain. A comparison with national subjects.
Castilla J; Sobrino P; del Amo J;
Sex Transm Infect; 2002 Aug; 78(4):250-4. PubMed ID: 12181461
[TBL] [Abstract][Full Text] [Related]
53. Cohort profile: The Kilombero and Ulanga Antiretroviral Cohort (KIULARCO) - A prospective HIV cohort in rural Tanzania.
Letang E; Kalinjuma AV; Glass TR; Gamell A; Mapesi H; Sikalengo GR; Luwanda LB; Mnzava D; Ntamatungiro AJ; Ndaki R; Francis G; Vanobberghen F; Furrer H; Klimkait T; Felger I; Tanner M; Hatz C; Weisser M; Battegay M; Kiularco Study Group
Swiss Med Wkly; 2017; 147():w14485. PubMed ID: 28695551
[TBL] [Abstract][Full Text] [Related]
54. Increased risk of non-AIDS-related events in HIV subjects with persistent low CD4 counts despite cART in the CoRIS cohort.
Pacheco YM; Jarrin I; Rosado I; Campins AA; Berenguer J; Iribarren JA; Rivero M; Muñoz-Medina L; Bernal-Morell E; Gutiérrez F; Leal M;
Antiviral Res; 2015 May; 117():69-74. PubMed ID: 25766861
[TBL] [Abstract][Full Text] [Related]
55. Characteristics and response to antiretroviral therapy of HIV-1-infected patients born in Africa and living in France.
Breton G; Lewden C; Spire B; Salmon D; Brun-Vézinet F; Duong M; Allavena C; Leport C; Salamon R;
HIV Med; 2007 Apr; 8(3):164-70. PubMed ID: 17461860
[TBL] [Abstract][Full Text] [Related]
56. [HIV infection in immigrants: clinical and epidemiological differences as compared to the native population in a Health Area in Madrid (2002-2004)].
Jerez AH; García-Cerrada C; Ortega FP; García RR; Gómez RH; González CC; Pérez-Herrero JR
Enferm Infecc Microbiol Clin; 2007; 25(7):441-5. PubMed ID: 17692212
[TBL] [Abstract][Full Text] [Related]
57. Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells/microL?
; Mocroft A; Reiss P; Kirk O; Mussini C; Girardi E; Morlat P; Stephan C; De Wit S; Doerholt K; Ghosn J; Bucher HC; Lundgren JD; Chene G; Miro JM; Furrer H
Clin Infect Dis; 2010 Sep; 51(5):611-9. PubMed ID: 20645862
[TBL] [Abstract][Full Text] [Related]
58. Spectrum of disease in persons with human immunodeficiency virus infection in the United States.
Farizo KM; Buehler JW; Chamberland ME; Whyte BM; Froelicher ES; Hopkins SG; Reed CM; Mokotoff ED; Cohn DL; Troxler S
JAMA; 1992 Apr; 267(13):1798-805. PubMed ID: 1347573
[TBL] [Abstract][Full Text] [Related]
59. Recent trends in Pneumocystis carinii pneumonia as AIDS-defining disease in nine European countries. Coordinators for AIDS Surveillance.
Delmas MC; Schwoebel V; Heisterkamp SH; Downs AM; Ancelle-Park RA; Brunet JB
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 May; 9(1):74-80. PubMed ID: 7712237
[TBL] [Abstract][Full Text] [Related]
60. Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study.
Furrer H; Egger M; Opravil M; Bernasconi E; Hirschel B; Battegay M; Telenti A; Vernazza PL; Rickenbach M; Flepp M; Malinverni R
N Engl J Med; 1999 Apr; 340(17):1301-6. PubMed ID: 10219064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
